SCHEMBL19735685

SCHEMBL19735685

Clc1ccc(-c2ccc(C3(c4ccccc4)c4ccccc4C4(c5ccccc5)c5ccccc5-c5cccc3c54)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
KDM4E B2RXH2 1/20 0.46
LMNA P02545 1/20 0.46
MAPT P10636 1/20 0.46
OPRK1 P41145 1/20 0.46
CYP1A2 P05177 2/20 0.42
PDK2 Q15119 5/20 0.41
CYP2C19 P33261 1/20 0.39
HIF1A Q16665 1/20 0.39
POLB P06746 1/20 0.37
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
SLC6A3 Q01959 2/20 0.36
MDM2 Q00987 4/20 0.35
CFTR P13569 1/20 0.33
GOPC Q9HD26 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17805156 0.92 MEN1 (0.53) MEN1KMT2ASMN1; SMN2KDM4ELMNA
SCHEMBL19735695 0.91 PDK2 (0.44) MEN1KMT2ASMN1; SMN2KDM4ELMNA
SCHEMBL5355967 0.88 MEN1 (0.57) MEN1KMT2ASMN1; SMN2KDM4ELMNA
SCHEMBL24155407 0.87 MEN1 (0.59) MEN1KMT2ASMN1; SMN2KDM4ELMNA
SCHEMBL22173459 0.86 PDK2 (0.47) MEN1KMT2ASMN1; SMN2KDM4ELMNA
SCHEMBL22151041 0.86 CYP1A2 (0.46) MEN1KMT2ASMN1; SMN2KDM4ELMNA
SCHEMBL22173211 0.84 PDK2 (0.48) MEN1KMT2ASMN1; SMN2KDM4ELMNA
SCHEMBL19735666 0.84 MEN1 (0.46) MEN1KMT2ASMN1; SMN2KDM4ELMNA
SCHEMBL30716820 0.84 MEN1 (0.46) MEN1KMT2ASMN1; SMN2KDM4ELMNA
SCHEMBL34464613 0.84 PDK2 (0.48) MEN1KMT2ASMN1; SMN2KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3369719-B1 SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEMICAL LTD (KR) 2020-02-26 EP disclosed
US-9960357-B2 Spiro-type compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2018-05-01 US disclosed
US-9960357-B2 Spiro-type compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2018-05-01 US disclosed
US-20170365787-A1 SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2017-12-21 US disclosed
US-20170365787-A1 SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2017-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170365787-A1 SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, NR2E3, LEF1 MEN1 426/4885KMT2A 1141/4885SMN1; SMN2 3563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.